Ignite Creation Date:
2025-12-25 @ 2:11 AM
Ignite Modification Date:
2025-12-30 @ 9:52 AM
Study NCT ID:
NCT05388760
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-11-05
First Post:
2022-05-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tralokinumab Monotherapy for Children With Moderate-to-severe Atopic Dermatitis - TRAPEDS 1 (TRAlokinumab PEDiatric Trial no. 1)
Sponsor:
LEO Pharma
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-09-07
Start Date Type:
ACTUAL
Primary Completion Date:
2023-10-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-04-23
Completion Date Type:
ESTIMATED
First Submit Date:
2022-05-19
First Submit QC Date:
None
Study First Post Date:
2022-05-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2024-10-21
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-11-03
Last Update Post Date:
2025-11-05
Last Update Post Date Type:
ESTIMATED